1. 353 HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinoma. (September 2015) Authors: Wong, S.; Cheng, W.; Wakefield, D.; Almeida, A.; Blokhin, A.; Almeida, L.; Hamilton, H.; Subbotin, V.; Hegge, J.; Bertin, S.; Milarch, T.; Schmidt, R.; Neal, Z.; Perillo-Nicholas, A.; Zhang, G.; Montez, J.; Andersen, A.; Rozema, D.; Lewis, D.; Kanner, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗